Serious complications from tricyclic antidepressant (TCA) overdose are uncommon1,2,3. We present a case of massive imipramine overdose complicated by ventricular fibrillation and a prolonged period of cardiovascular collapse. A total of 400 mmol of sodium bicarbonate, 5 mg of adrenaline and 80 mg of sotalol were given during 50 minutes of cardiac arrest. The patient made a full recovery with no apparent neurological sequelae. The highest TCA plasma level we could find in the published literature was 4873 ng/ml4; our patient's peak TCA level was 6000 ng/ml. Tricyclic antidepressant overdose is a common cause of intensive care unit admission. It has a low mortality rate.
HendersonA., WrightM., PondS.M.Experience with 732 acute overdose patients admitted to an intensive care unit over six years.Med J Aust1993; 158: 28–20.
2.
EllisonD., PentelP.Clinical features and consequences of seizures due cyclic antidepressant overdose.Am J Emerg Med1989; 7: 5–10.
3.
GoldberyR., CaponeR., HuntJ.Cardiac complications following TCA overdose.JAMA1985; 254: 1772–1775.
4.
BoehnertM., LovejoyF.Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of TCA.New Eng J Med1985; 313: 474–479.
BrownT.The use of sodium bicarbonate in the treatment of tricyclic antidepressant-induced arrhythmias.Anaesth Intensive Care1973; 1: 203–210.
9.
HenryJ., CassidyS.Membrane stabilising activity: a major cause of fatal poisoning.Lancet1986; 1: 1414–1418.
10.
BrownT.C.K.Sodium bicarbonate treatment for tricyclic anti-depressant antiarrhythmias in children.Med J Aust1976; 2: 380–382.
11.
SwartzC., ShermanA.The treatment of TCA overdose with repeated charcoal.J Clin Psychopharmacol1984; 4: 336–340.
12.
BarberM.J., StamerC.F., GrantA.O.Blockade of cardiac sodium channels by amitriptyline and diphenylhydantoin.Circ Res1991; 69: 677–696.
13.
HagermanG.A., HanashiroP.K.Reversal of tricyclic anti-depressant induced cardiac conduction abnormalities by phenytoin.Ann Emerg Med1981; 10: 82–86.
14.
FittonA., SorkinE.M.Sotalol. An updated review of its pharmacological and therapeutic use in cardiac arrhythmias.Drugs1993; 46: 678–719.
15.
CavusogluE., FreshmanW.H.Sotalol: A new beta-adrenergic blocker for ventricular arrhythmias.Prog Cardiovasc Dis1995; 37: 423–440.
16.
KirschembaumH.L., RosenbergJ.M.Clinical experience with sotalol in the treatment of cardiac arrhythmias.Clin Ther1994; 16: 346–364.
17.
FreedmanR.A., KaragounisL.A., SteinbergJ.S.Effects of sotalol on the signal-averaged electrocardiogram in patients with sustained ventricular tachycardia: relation to suppression of inducibility and changes in tachycardia cycle length.J Am Coll Cardiol1992; 20: 1213–1219.
18.
TouboulP.Electrophysiologic properties of sotalol and D-sotalol.Eur Heart J1993; 14(Suppl H): 24–29.
19.
HohnloserS.H., SinghB.N.Proarrhythmias with class III anti-arrhythmic drugs: definition, electrophysiologic mechanism, incidence, predisposing factors, and clinical implications.J Cardiovasc Electrophysiol1995; 6: 920–936.
20.
ClaudelJ.P., TouboulP.Sotalol: From “just another beta blocker” to “the prototype of class III antidysrrhythmic compound”.Pacing Clin Electrophysiol1995; 18: 451–467.
21.
NakataN., KatoH., KogureK.Protective effects of serotonin reuptake inhibitors, citalopram and clomipramine, against hippocampal CA1 neuronal damage following transient ischemia in the gerbil.Brain Res1992; 590: 48–52.
22.
RaoT.S., ClerJ.A., MickS.J.Opipramol, a potent sigma ligand, is an anti-ischemic agent: Neurochemical evidence for an interaction with the N-methyl-D-aspartate receptor complex in vivo by cerebellar cGMP measurements.Neuropharmacology1990; 29: 1199–1204.
